cc-292
Showing 1 - 5 of 5
Lymphoma, Large B-Cell, Diffuse Trial in Worldwide (CC-122, CC-223, Rituximab)
Active, not recruiting
- Lymphoma, Large B-Cell, Diffuse
- CC-122
- +3 more
-
Santa Barbara, California
- +22 more
Jan 25, 2023
Healthy Volunteers Trial in Evansville (CC-292, Oral Omeprazole (OMP))
Completed
- Healthy Volunteers
- CC-292
- Oral Omeprazole (OMP)
-
Evansville, IndianaCovance Clinical Research unit
Aug 11, 2020
Leukemia Lymphocytic Chronic B-Cell Trial in Austria, United States (CC-292, Lenalidomide)
Completed
- Leukemia Lymphocytic Chronic B-Cell
- CC-292
- Lenalidomide
-
Huntsville, Alabama
- +10 more
Dec 19, 2019
Rheumatoid Arthritis Trial in United States (CC-292, Placebo)
Completed
- Rheumatoid Arthritis
- CC-292
- Placebo
-
Birmingham, Alabama
- +26 more
Jul 27, 2017
Leukemia Lymphocytic Chronic B-Cell Trial in Germany, United States (CC-292, Rituximab)
Completed
- Leukemia Lymphocytic Chronic B-Cell
- CC-292
- Rituximab
-
Huntsville, Alabama
- +7 more
Apr 18, 2016